Common Contracts
8 similar Grant Agreement contracts
GRANT AGREEMENTGrant Agreement • May 17th, 2022
This Grant Agreement (“Agreement”) is entered into as of May 17 2022 (“Effective Date”) by and between Novartis Healthcare A/S, Reg. No. 20575786, a company incorporated under the laws of Denmark, located at Edvard Thomsens Vej 14, DK-2300 Copenhagen S, Denmark (“Novartis”) and Lyle -Patientforeningen for Lymfekræft, Leukæmi og MDS. CVR-nummer: 31 30 68 33, a Organization incorporated under the laws of Denmark, located at Banetoften 26, 4700 Næstved , (“Grant Recipient”). Novartis and Grant Recipient may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
GRANT AGREEMENTGrant Agreement • March 27th, 2020
This Grant Agreement (“Agreement”) is entered into as of the 27th of March 2020 (“Effective Date”) by and between Novartis Healthcare A/S, Reg. No. 20575786, a company
GRANT AGREEMENTGrant Agreement • January 7th, 2020
This Grant Agreement (“Agreement”) is entered into as of 07.01.2020 (“Effective Date”) by and between Novartis Healthcare A/S, Reg. No. 20575786, a company incorporated under the laws of Denmark, located at Edvard Thomsens Vej 14, DK-2300 Copenhagen S, Denmark (“Novartis”) and Øjenforeningen, an organization incorporated under the laws of Denmark, located at
GRANT AGREEMENTGrant Agreement • January 7th, 2020
This Grant Agreement (“Agreement”) is entered into as of 07.01.2020 (“Effective Date”) by and between Novartis Healthcare A/S, Reg. No. 20575786, a company incorporated under the laws of Denmark, located at Edvard Thomsens Vej 14, DK-2300 Copenhagen S, Denmark (“Novartis”) and Øjenforeningen, an organization incorporated under the laws of Denmark, located at
GRANT AGREEMENTGrant Agreement • June 17th, 2019
This Grant Agreement (“Agreement”) is entered into as of June 17, 2019 (“Effective Date”) by and between Novartis Healthcare A/S, Reg. No. 20575786, a company incorporated under the laws of Denmark, located at Edvard Thomsens Vej 14, DK-2300 Copenhagen S, Denmark (“Novartis”) and LyLe , an organization incorporated under the laws of Denmark, located at Banetoften 26, 4700 Næstved, (“Grant Recipient”). Novartis and Grant Recipient may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
GRANT AGREEMENTGrant Agreement • April 12th, 2019
This Grant Agreement (“Agreement”) is entered into as of 12th of April 2019 (“Effective Date”) by and between Novartis Healthcare A/S, Reg. No. 20575786, a company incorporated under the laws of Denmark, located at Edvard Thomsens Vej 14, DK-2300 Copenhagen S, Denmark
GRANT AGREEMENTGrant Agreement • April 11th, 2019
This Grant Agreement (“Agreement”) is entered into as of 10.04.2019 (“Effective Date”) by and between Novartis Healthcare A/S, Reg. No. 20575786, a company incorporated under the laws of Denmark, located at Edvard Thomsens Vej 14, DK-2300 Copenhagen S, Denmark (“Novartis”) and Øjenforeningen, an organization incorporated under the laws of Denmark, located at
GRANT AGREEMENTGrant Agreement • January 1st, 2019
This Grant Agreement (“Agreement”) is entered into as of December 28, 2018 (“Effective Date”) by and between Novartis Healthcare A/S, Reg. No. 20575786, a company incorporated under the laws of Denmark, located at Edvard Thomsens Vej 14, DK-2300 Copenhagen S, Denmark (“Novartis”) and LYLE – CVR 31306833, a patient organization incorporated under the laws of Denmark, located at Banetoften 26, 4700 Næstved (“Grant Recipient”). Novartis and Grant Recipient may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
